Why Did Nature's Sunshine Plunge 12.26%? Secondary Offering Fears

On June 26, 2025, Nature's Sunshine experienced a significant drop of 12.26% in pre-market trading, marking a notable decline in its stock performance.

Nature's Sunshine Products, Inc. recently announced the pricing of a secondary public offering of common stock. This offering involves the sale of up to 2,854,607 shares by Fosun Pharma USA, Inc. The shares are priced at $12.00 each, which could potentially dilute the value of existing shares and impact investor sentiment.

The company's decision to launch this secondary offering comes at a time when the market is already experiencing volatility. The sale of a large number of shares by a major shareholder like Fosun Pharma USA could signal a lack of confidence in the company's future prospects, leading to further declines in stock price.

Investors are closely monitoring the situation, as the outcome of this offering could have significant implications for Nature's Sunshine's financial health and market position. The company's management will need to address these concerns and provide reassurance to shareholders to stabilize the stock price.